Brandes Investment Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.5M Buy
245,306
+22,395
+10% +$6.06M 0.46% 78
2025
Q4
$55.9M Sell
222,911
-352
-0.2% -$93.5K 0.43% 77
2025
Q3
$64.1M Buy
223,263
+17,616
+9% +$4.72M 0.51% 69
2025
Q2
$54M Sell
205,647
-279,196
-58% -$68M 0.49% 72
2025
Q1
$113M Sell
484,843
-83,881
-15% -$20.4M 1.15% 32
2024
Q4
$130M Buy
568,724
+67,002
+13% +$15.4M 1.46% 22
2024
Q3
$112M Buy
501,722
+7,654
+2% +$1.68M 1.26% 30
2024
Q2
$101M Buy
494,068
+99,912
+25% +$20.3M 1.24% 32
2024
Q1
$86.1M Buy
394,156
+60,019
+18% +$13.2M 1.11% 35
2023
Q4
$75.9M Buy
334,137
+40,682
+14% +$8.55M 1.15% 34
2023
Q3
$59M Buy
293,455
+21,133
+8% +$4.46M 1.15% 32
2023
Q2
$56.5M Sell
272,322
-9,373
-3% -$1.82M 1.14% 31
2023
Q1
$55.5M Buy
281,695
+53,638
+24% +$11M 1.18% 32
2022
Q4
$46.1M Sell
228,057
-11,756
-5% -$2.3M 1.29% 32
2022
Q3
$42.2M Buy
239,813
+20,391
+9% +$4.17M 1.1% 30
2022
Q2
$44.2M Buy
219,422
+4,489
+2% +$957K 1.08% 32
2022
Q1
$48.7M Buy
214,933
+11,006
+5% +$2.59M 1.04% 33
2021
Q4
$55M Sell
203,927
-20,740
-9% -$5.13M 1.2% 30
2021
Q3
$54.3M Sell
224,667
-30,108
-12% -$7.59M 1.18% 32
2021
Q2
$60.4M Sell
254,775
-12,522
-5% -$2.85M 1.34% 23
2021
Q1
$58.2M Buy
267,297
+1,384
+0.5% +$278K 1.38% 24
2020
Q4
$46M Sell
265,913
-73,201
-22% -$12.6M 1.19% 31
2020
Q3
$54.8M Sell
339,114
-53,357
-14% -$8.46M 1.9% 14
2020
Q2
$56M Sell
392,471
-26,978
-6% -$3.73M 1.71% 18
2020
Q1
$45.5M Sell
419,449
-3,888
-0.9% -$560K 1.59% 20
2019
Q4
$61.5M Sell
423,337
-9,308
-2% -$1.34M 1.46% 23
2019
Q3
$62.4M Sell
432,645
-19,815
-4% -$2.89M 1.61% 18
2019
Q2
$67.2M Sell
452,460
-20,244
-4% -$2.82M 1.5% 19
2019
Q1
$62.1M Buy
472,704
+70,111
+17% +$8.64M 1.44% 22
2018
Q4
$43.7M Buy
402,593
+341,580
+560% +$45.8M 1.11% 30
2018
Q3
$9.1M Sell
61,013
-4,074
-6% -$620K 0.21% 72
2018
Q2
$10M Sell
65,087
-1,942
-3% -$293K 0.23% 70
2018
Q1
$9.31M Sell
67,029
-5,605
-8% -$823K 0.2% 74
2017
Q4
$9.95M Sell
72,634
-6,374
-8% -$842K 0.2% 76
2017
Q3
$10.2M Sell
79,008
-45,113
-36% -$6.02M 0.21% 74
2017
Q2
$16.4M Sell
124,121
-236
-0.2% -$28.9K 0.26% 69
2017
Q1
$15.3M Buy
124,357
+61,244
+97% +$7.25M 0.23% 73
2016
Q4
$6.96M Buy
+63,113
New +$7.01M 0.1% 91
2015
Q1
Sell
-137,011
Closed -$12.7M 188
2014
Q4
$12.7M Sell
137,011
-55,858
-29% -$4.93M 0.18% 74
2014
Q3
$16.9M Buy
192,869
+13,383
+7% +$1.21M 0.22% 59
2014
Q2
$15.8M Buy
179,486
+6,370
+4% +$552K 0.19% 62
2014
Q1
$14.6M Buy
173,116
+5,453
+3% +$435K 0.18% 67
2013
Q4
$13.2M Buy
167,663
+23,755
+17% +$2.03M 0.16% 68
2013
Q3
$12.3M Buy
143,908
+8,400
+6% +$707K 0.16% 69
2013
Q2
$11.7M Buy
+135,508
New +$11.2M 0.15% 72

Other funds holding LH

Brandes Investment Partners's LH Position: Q1 2026 in Review

Brandes Investment Partners increased its Labcorp (LH) stake by 10% in Q1 2026, buying an estimated $6.06M and bringing the position to 245,306 shares worth $65.5M. The position accounts for 0.46% of the portfolio, ranked #78.

Brandes Investment Partners first reported a position in LH in Q2 2013 and has held it in 45 quarters since. The position peaked at $130M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Brandes Investment Partners held 245,306 shares of Labcorp worth $65.5M as of Q1 2026.
  • Brandes Investment Partners bought 22,395 Labcorp shares in Q1 2026, an estimated $6.06M.
  • Labcorp made up 0.46% of Brandes Investment Partners's portfolio in Q1 2026, its #78 holding.
  • Brandes Investment Partners first reported a position in Labcorp in Q2 2013 and has held it in 45 quarters since.
  • Brandes Investment Partners's Labcorp position peaked at $130M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.